6472
COM:BORA-CORP
Bora Pharmaceuticals
- Stock
Last Close
780.00
22/11 05:30
Market Cap
86.08B
Beta: -
Volume Today
1.19M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '22 | Dec '22 | Mar '23 | Jun '23 | Sep '23 | Dec '23 | Mar '24 | Jun '24 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | 568.88M - | 403.87M 29.01% | 1.44B 257.15% | 1.02B 29.35% | 923.02M 9.42% | 679.66M 26.37% | 983.54M 44.71% | 1.51B 53.71% | |
depreciation and amortization | 79.10M - | 119.85M 51.51% | 133.68M 11.54% | 137.76M 3.05% | 150.57M 9.30% | 184.28M 22.38% | 191.35M 3.84% | 251.62M 31.50% | |
deferred income tax | |||||||||
stock based compensation | 10.30M - | 13.46M 30.64% | 17.42M 29.41% | 21.33M 22.43% | 17.65M 17.24% | 46.41M 162.95% | 43.76M 5.73% | 26.50M 39.44% | |
change in working capital | -22.03M - | 333.78M 1,614.83% | 440.20M 31.88% | -398.40M 190.50% | -546.19M 37.09% | 12.45M 102.28% | 26.28M 111.04% | -2.17B 8,345.80% | |
accounts receivables | -1.24B - | -295.53M 76.15% | |||||||
inventory | -141.35M - | 379.96M 368.81% | 151.91M 60.02% | -186.50M 222.77% | -333.06M 78.59% | 243.14M 173.00% | -225.48M 192.74% | -43.21M 80.84% | |
accounts payables | |||||||||
other working capital | 1.36B - | 249.35M 81.64% | |||||||
other non cash items | 182.77M - | -71.97M 139.38% | 38.07M 152.89% | 24.87M 34.66% | 31.18M 25.34% | 22.57M 27.62% | 29.22M 29.50% | -669.82M 2,392.11% | |
net cash provided by operating activities | 819.03M - | 798.99M 2.45% | 1.97B 145.99% | 778.61M 60.38% | 714.10M 8.29% | 1.16B 61.82% | 1.24B 7.03% | -2.10B 269.42% | |
investments in property plant and equipment | -62.64M - | -76.94M 22.83% | -66.17M 14.00% | -109.42M 65.37% | -1.15B 953.62% | -101.72M 91.18% | -201.34M 97.93% | -133.83M 33.53% | |
acquisitions net | -4.50B - | -518K 99.99% | -1.23B - | -61.64M 94.98% | 288.42M 567.92% | -1.39M 100.48% | -7.76B 557,468.25% | ||
purchases of investments | 78.02M - | -78.02M 200% | 53.65M - | -303.57M 665.86% | -1.74B 474.47% | ||||
sales maturities of investments | -6.29M - | -211.97M 3,272.18% | 280.95M 232.54% | 233.25M 16.98% | |||||
other investing activites | 110.86M - | 471.59M 325.40% | -1.43M 100.30% | 5.80M 506.94% | -1.85M 131.86% | 8.39M 553.98% | -260.86M 3,207.66% | -3.75M 98.56% | |
net cash used for investing activites | -4.45B - | 394.13M 108.86% | 10.43M 97.35% | -1.28B 12,384.02% | -1.22B 4.46% | 36.77M 103.00% | -480.70M 1,407.36% | -9.42B 1,858.61% | |
debt repayment | -2.92B - | -531.24M 81.81% | -376.24M 29.18% | -105.56M 71.94% | -840.38M 696.10% | -2.05B 144.31% | -4.06B 97.87% | -9.41B 131.65% | |
common stock issued | 5.61M - | 1.20M 78.69% | 6.59M 451.25% | 20.54M 211.47% | 10.20M 50.32% | 1.07M 89.55% | |||
common stock repurchased | |||||||||
dividends paid | -238.80M - | ||||||||
other financing activites | 809.01M - | -569.11M 170.35% | -14.94M 97.38% | 14.07M 194.20% | 74.42M 428.94% | -3.27M 104.39% | 83.29M 2,650.93% | -100.05M 220.13% | |
net cash used provided by financing activities | 3.49B - | -1.10B 131.52% | -443.48M 59.70% | -156.22M 64.77% | 247.99M 258.74% | -2.09B 942.17% | 4.11B 296.77% | 8.80B 114.20% | |
effect of forex changes on cash | 11.06M - | -13.70M 223.86% | -6.49M 52.61% | 56.19M 965.42% | 193.07M 243.60% | -186.65M 196.67% | 146.64M 178.57% | 152.22M 3.81% | |
net change in cash | -128.48M - | 79.07M 161.54% | 1.53B 1,829.82% | -602.40M 139.48% | -68.64M 88.61% | -1.08B 1,477.56% | 5.01B 562.88% | -2.56B 150.99% | |
cash at beginning of period | 3.33B - | 3.20B 3.86% | 3.28B 2.47% | 4.81B 46.50% | 4.20B 12.53% | 4.14B 1.63% | 3.05B 26.18% | 8.07B 164.16% | |
cash at end of period | 3.20B - | 3.28B 2.47% | 4.81B 46.50% | 4.20B 12.53% | 4.14B 1.63% | 3.05B 26.18% | 8.07B 164.16% | 5.51B 31.69% | |
operating cash flow | 819.03M - | 798.99M 2.45% | 1.97B 145.99% | 778.61M 60.38% | 714.10M 8.29% | 1.16B 61.82% | 1.24B 7.03% | -2.10B 269.42% | |
capital expenditure | -62.64M - | -76.94M 22.83% | -66.17M 14.00% | -109.42M 65.37% | -1.15B 953.62% | -101.72M 91.18% | -201.34M 97.93% | -133.83M 33.53% | |
free cash flow | 756.38M - | 722.04M 4.54% | 1.90B 163.04% | 669.19M 64.77% | -438.78M 165.57% | 1.05B 340.17% | 1.04B 1.74% | -2.23B 315.29% |
All numbers in (except ratios and percentages)